1. Eugenol has sedative and analgesic effects, can inhibit the GABAA current in trigeminal ganglion neurons.
2. Eugenol inhibits early root growth through ROS-mediated oxidative damage, despite an activation of the antioxidant enzyme machinery.
3. Eugenol could be developed as therapeutic agent against diseases with excessive osteoclast activity.
4. Eugenol can inhibit the proliferation of HT-29 cells and the mRNA expression of COX-2, but not COX-1, suggests that eugenol might be a plausible lead candidate for further developing the COX-2 inhibitor as an anti-inflammatory or cancer chemopreventive agent.
5. Eugenol acts as an antibacterial agent against Salmonella typhi by disrupting the cellular membrane.
6. Eugenol has anthelmintic activity against Haemonchus contortus.
7. Eugenol and curcumin are good inhibitors of lipid peroxidation, lipid peroxidation is known to be initiated by reactive oxygen species; they also prevent the oxidation of Fe2+ in Fentons reaction which generates .OH radicals.
1. Anagyrine can induce red cell aplasia, vascular anomaly, and skeletal dysplasia.
2.(-)-Anagyrine and (-)--Methylcytisine have nematicidal activities against Pine Wood Nematodes.
3. Anagyrine, is the responsible teratogen from teratogenic lupins, can produce congenital deformities in calves typical of crooked calf disease.